Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
An AstraZeneca win in bladder cancer, and more
AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial
Imfinzi is a human monoclonal antibody that targets the PD-L1 protein, whereas Imjudo focuses on the CTLA-4 protein.
News from ESMO: An AstraZeneca win in bladder cancer, and more
AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.
AstraZeneca’s blockbuster drug scores major win in bladder cancer
In patients with muscle-invasive bladder cancer, Imfinzi reduced the risk of disease recurring by 32% when given alongside the current standard of care, interim analysis of a late-stage trial found. The medicine also reduced the risk of death by a quarter when added to current treatments such as chemotherapy and surgery,
2h
AstraZeneca falls Tuesday, underperforms market
AstraZeneca PLC AZN shares inched down 0.40% to £119.68 Tuesday, on what proved to be an all-around great trading session for ...
1d
Sanofi, AstraZeneca win US approval for RSV therapy manufacturing line
Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...
7h
'Human error and tragic timing' meant Suffolk man was wrongly given AstraZeneca Covid-19 vaccine
Jack Last, 27, died from a blood clot as a "direct result" from getting the Covid-19 vaccine, with an independent report ...
21h
AstraZeneca PLC ADR rises Monday, outperforms market
The AstraZeneca PLC ADR AZN inched 0.98% higher to $79.04 Monday, on what proved to be an all-around mixed trading session ...
4d
AstraZeneca Shares Set For Worst Week in 14 Months on Sell Calls
AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the ...
FierceBiotech
3d
ESMO: AstraZeneca steps out from Daiichi's shadow, posting data on ADC rivals to AbbVie, Pfizer
AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...
5h
Healthy 27-year-old died after NHS wrongly gave him AstraZeneca Covid jab
A healthy 27-year-old died from a reaction to the AstraZeneca vaccine after NHS mistakes meant he wrongly got the jab, a report has found.
7d
on MSN
AstraZeneca Defends China Compliance In Wake of Staff Detentions
AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of ...
7d
AstraZeneca stock drops after lung cancer drug trial setback
London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that ...
14h
AstraZeneca and MSD hail progress in hard-to-treat cancers
Two of the world’s biggest drugmakers — AstraZeneca and MSD — have hailed progress in tackling hard-to-treat cancers, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Dow Jones Industrial Average
Imfinzi
Daiichi Sankyo
Deutsche Bank
Truqap
Feedback